WM-3835 is primarily used as a research compound in the study of inflammatory pathways and immune responses. It functions as a selective inhibitor of certain kinases involved in signal transduction, making it a valuable tool in probing cellular mechanisms related to inflammation and autoimmune diseases. Due to its specificity, it is employed in preclinical studies to evaluate the therapeutic potential of kinase inhibition in conditions such as rheumatoid arthritis, inflammatory bowel disease, and other chronic inflammatory disorders. Its application is largely confined to laboratory and experimental settings, where it aids in target validation and pathway analysis.